Innoviva, Inc.
(NASDAQ : INVA)

( )
INVA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
1.87%24.471.7%$256.98m
VRXValeant Pharmaceuticals International, Inc.
2.63%28.4814.1%$167.58m
BHCBausch Health Cos., Inc.
2.63%28.480.0%$119.07m
GWPHGW Pharmaceuticals Plc
2.26%108.416.2%$82.69m
MDCOThe Medicines Co.
0.10%52.0320.2%$80.80m
JAZZJazz Pharmaceuticals Plc
3.60%138.642.3%$64.51m
SAGESAGE Therapeutics, Inc.
3.93%146.328.6%$52.92m
PRGOPerrigo Co. Plc
-0.67%49.076.8%$49.70m
ENDPEndo International Plc
0.44%4.558.8%$45.74m
UTHRUnited Therapeutics Corp.
1.01%90.4314.3%$39.52m
HZNPHorizon Therapeutics Plc
1.51%30.266.6%$38.93m
ICPTIntercept Pharmaceuticals, Inc.
-2.61%80.1016.9%$37.80m
ICLRICON plc
1.42%154.594.2%$37.69m
CTLTCatalent, Inc.
2.65%50.412.4%$31.87m
ARGXargenx SE
1.45%139.370.0%$26.47m

Company Profile

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.